Does ROSUVASTATIN Cause Skin atrophy? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Skin atrophy have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
18
Reports of Skin atrophy with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Skin atrophy From ROSUVASTATIN?
Of the 18 reports, 2 (11.1%) required hospitalization.
Is Skin atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Skin atrophy?
DUPILUMAB (262)
PREDNISONE (258)
ADALIMUMAB (205)
METHOTREXATE (191)
ETANERCEPT (139)
CLOBETASOL (123)
SECUKINUMAB (121)
IBRUTINIB (112)
TRIAMCINOLONE ACETONIDE (110)
HYDROCORTISONE (106)
Which ROSUVASTATIN Alternatives Have Lower Skin atrophy Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN